204 related articles for article (PubMed ID: 25782469)
1. Pharmacodynamic interactions of a solid formulation of sodium oxybate and ethanol in healthy volunteers.
Pross N; Patat A; Vivet P; Bidaut M; Fauchoux N
Br J Clin Pharmacol; 2015 Sep; 80(3):480-92. PubMed ID: 25782469
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological interactions between brivaracetam and ethanol in healthy males.
Kruithof AC; Watanabe S; Peeters PA; de Kam ML; Zuiker RG; Stevens J; van Gerven JM; Stockis A
J Psychopharmacol; 2017 Jul; 31(7):915-926. PubMed ID: 27649776
[TBL] [Abstract][Full Text] [Related]
3. Sodium oxybate for the maintenance of abstinence in alcohol-dependent patients: An international, multicenter, randomized, double-blind, placebo-controlled trial.
Guiraud J; Addolorato G; Antonelli M; Aubin HJ; de Bejczy A; Benyamina A; Cacciaglia R; Caputo F; Dematteis M; Ferrulli A; Goudriaan AE; Gual A; Lesch OM; Maremmani I; Mirijello A; Nutt DJ; Paille F; Perney P; Poulnais R; Raffaillac Q; Rehm J; Rolland B; Rotondo C; Scherrer B; Simon N; Skala K; Söderpalm B; Somaini L; Sommer WH; Spanagel R; Vassallo GA; Walter H; van den Brink W
J Psychopharmacol; 2022 Oct; 36(10):1136-1145. PubMed ID: 35796481
[TBL] [Abstract][Full Text] [Related]
4. Treating alcohol dependence with an abuse and misuse deterrent formulation of sodium oxybate: Results of a randomised, double-blind, placebo-controlled study.
Guiraud J; Addolorato G; Aubin HJ; Batel P; de Bejczy A; Caputo F; Goudriaan AE; Gual A; Lesch O; Maremmani I; Perney P; Poulnais R; Raffaillac Q; Soderpalm B; Spanagel R; Walter H; van den Brink W;
Eur Neuropsychopharmacol; 2021 Nov; 52():18-30. PubMed ID: 34237655
[TBL] [Abstract][Full Text] [Related]
5. The effects of ethanol on the pharmacokinetics, pharmacodynamics, safety, and tolerability of ezogabine (retigabine).
Crean CS; Tompson DJ
Clin Ther; 2013 Jan; 35(1):87-93. PubMed ID: 23328270
[TBL] [Abstract][Full Text] [Related]
6. Sodium oxybate in the treatment of alcohol withdrawal syndrome: a randomized double-blind comparative study versus oxazepam. The GATE 1 trial.
Caputo F; Skala K; Mirijello A; Ferrulli A; Walter H; Lesch O; Addolorato G
CNS Drugs; 2014 Aug; 28(8):743-52. PubMed ID: 24996524
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological Interactions between the Dual Orexin Receptor Antagonist Daridorexant and Ethanol in a Double-Blind, Randomized, Placebo-Controlled, Double-Dummy, Four-Way Crossover Phase I Study in Healthy Subjects.
Berger B; Brooks S; Zuiker R; Richard M; Muehlan C; Dingemanse J
CNS Drugs; 2020 Dec; 34(12):1253-1266. PubMed ID: 33205362
[TBL] [Abstract][Full Text] [Related]
8. Cognitive, psychomotor, and subjective effects of sodium oxybate and triazolam in healthy volunteers.
Carter LP; Griffiths RR; Mintzer MZ
Psychopharmacology (Berl); 2009 Sep; 206(1):141-54. PubMed ID: 19543883
[TBL] [Abstract][Full Text] [Related]
9. Sodium oxybate in maintaining alcohol abstinence in alcoholic patients with and without psychiatric comorbidity.
Caputo F; Francini S; Brambilla R; Vigna-Taglianti F; Stoppo M; Del Re A; Leggio L; Addolorato G; Zoli G; Bernardi M
Eur Neuropsychopharmacol; 2011 Jun; 21(6):450-6. PubMed ID: 21276717
[TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamic interactions of diazepam and intravenous alcohol at pseudo steady state.
van Steveninck AL; Gieschke R; Schoemaker HC; Pieters MS; Kroon JM; Breimer DD; Cohen AF
Psychopharmacology (Berl); 1993; 110(4):471-8. PubMed ID: 7870919
[TBL] [Abstract][Full Text] [Related]
11. Post-marketing and clinical safety experience with sodium oxybate for the treatment of alcohol withdrawal syndrome and maintenance of abstinence in alcohol-dependent subjects.
Addolorato G; Lesch OM; Maremmani I; Walter H; Nava F; Raffaillac Q; Caputo F
Expert Opin Drug Saf; 2020 Feb; 19(2):159-166. PubMed ID: 31876433
[No Abstract] [Full Text] [Related]
12. Psychomotor effects, pharmacokinetics and safety of the orexin receptor antagonist suvorexant administered in combination with alcohol in healthy subjects.
Sun H; Yee KL; Gill S; Liu W; Li X; Panebianco D; Mangin E; Morrison D; McCrea J; Wagner JA; Troyer MD
J Psychopharmacol; 2015 Nov; 29(11):1159-69. PubMed ID: 26464455
[TBL] [Abstract][Full Text] [Related]
13. Further evidence supporting the use of sodium oxybate for the treatment of cataplexy: a double-blind, placebo-controlled study in 228 patients.
Xyrem International Study Group
Sleep Med; 2005 Sep; 6(5):415-21. PubMed ID: 16099718
[TBL] [Abstract][Full Text] [Related]
14. A single-center, randomized, double-blind, placebo-controlled, crossover investigation of the effects of fexofenadine hydrochloride 180 mg alone and with alcohol, with hydroxyzine hydrochloride 50 mg as a positive internal control, on aspects of cognitive and psychomotor function related to driving a car.
Ridout F; Shamsi Z; Meadows R; Johnson S; Hindmarch I
Clin Ther; 2003 May; 25(5):1518-38. PubMed ID: 12867226
[TBL] [Abstract][Full Text] [Related]
15. Effects of sibutramine alone and with alcohol on cognitive function in healthy volunteers.
Wesnes KA; Garratt C; Wickens M; Gudgeon A; Oliver S
Br J Clin Pharmacol; 2000 Feb; 49(2):110-7. PubMed ID: 10671904
[TBL] [Abstract][Full Text] [Related]
16. The pharmacokinetic and pharmacodynamic effects of SL65.1498, a GABA-A alpha2,3 selective agonist, in comparison with lorazepam in healthy volunteers.
de Haas SL; Franson KL; Schmitt JA; Cohen AF; Fau JB; Dubruc C; van Gerven JM
J Psychopharmacol; 2009 Aug; 23(6):625-32. PubMed ID: 18635696
[TBL] [Abstract][Full Text] [Related]
17. The effects of sodium oxybate on clinical symptoms and sleep patterns in patients with fibromyalgia.
Scharf MB; Baumann M; Berkowitz DV
J Rheumatol; 2003 May; 30(5):1070-4. PubMed ID: 12734908
[TBL] [Abstract][Full Text] [Related]
18. Psychomotor and subjective effects of bilastine, hydroxyzine, and cetirizine, in combination with alcohol: a randomized, double-blind, crossover, and positive-controlled and placebo-controlled Phase I clinical trials.
García-Gea C; Martínez J; Ballester MR; Gich I; Valiente R; Antonijoan RM
Hum Psychopharmacol; 2014 Mar; 29(2):120-32. PubMed ID: 24395298
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the central nervous system effects of alcohol at pseudo-steady state in Caucasian and expatriate Japanese healthy male volunteers.
Zoethout RW; de Kam ML; Dahan A; Cohen AF; van Gerven JM
Alcohol; 2012 Nov; 46(7):657-64. PubMed ID: 22832329
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of lower-sodium oxybate in adults with idiopathic hypersomnia: a phase 3, placebo-controlled, double-blind, randomised withdrawal study.
Dauvilliers Y; Arnulf I; Foldvary-Schaefer N; Morse AM; Šonka K; Thorpy MJ; Mignot E; Chandler P; Parvataneni R; Black J; Sterkel A; Chen D; Skobieranda F; Bogan RK
Lancet Neurol; 2022 Jan; 21(1):53-65. PubMed ID: 34942138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
